| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | http://www.jubilantingrevia.com | |
| Market Cap | 7,532.41 Cr. | |
| Enterprise Value(EV) | 7,827.00 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 22.68 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | 20.88 | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 25.90 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 160.50 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 2.95 | Calculated using Price: 473.70 |
| Dividend Yield | 1.06 | Period Ending 2022-03 |
| No. of Shares Subscribed | 15.93 Cr. | 159,281,139 Shares |
| FaceValue | 1 | |
| Company Profile | ||
| The company offers a broad portfolio of high-quality ingredients that find application in a wide range of industries. The company's portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. | ||
| 1 Day |
|
-1.66% |
| 1 Week |
|
-3.65% |
| 1 Month |
|
-10.35% |
| 3 Month |
|
-7.98% |
| 6 Month |
|
-10.49% |
| 1 Year |
|
-14.29% |
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 3 years | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 5.65 | 21.89 | ||
| Return on Capital Employed (%) | 6.86 | 28.84 | ||
| Return on Assets (%) | -332.00 | 3.23 | 13.34 |
| Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 0 | 1,923 | 2,433 | 2,556 | |
| Non Curr. Liab. | 549 | 296 | 220 | ||
| Curr. Liab. | 0 | 894 | 1,053 | 1,312 | |
| Minority Int. | |||||
| Equity & Liab. | 0 | 3,366 | 3,782 | 4,088 | |
| Non Curr. Assets | 1,943 | 2,018 | 2,173 | ||
| Curr. Assets | 0 | 1,424 | 1,765 | 1,915 | |
| Misc. Exp. not W/O | |||||
| Total Assets | 0 | 3,366 | 3,782 | 4,088 |
| Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
| Net Sales | 684 | 4,949 | 5,052 | ||
| Other Income | 3 | 31 | 36 | ||
| Total Income | 687 | 4,981 | 5,088 | ||
| Total Expenditure | 0 | -567 | -4,118 | -4,403 | |
| PBIDT | 0 | 120 | 863 | 685 | |
| Interest | -7 | -31 | -20 | ||
| Depreciation | -22 | -123 | -124 | ||
| Taxation | -23 | -232 | -180 | ||
| Exceptional Items | -13 | ||||
| PAT | 0 | 54 | 477 | 361 | |
| Minority Interest | |||||
| Share Associate | 0 | ||||
| Other Related Items | |||||
| Consolidated Net Profit | 0 | 54 | 477 | 361 | |
| Adjusted EPS | -3 | 3 | 30 | 23 |
| Particulars | 3 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 112 | 453 | ||
| Cash Fr. Inv. | -44 | -72 | ||
| Cash Fr. Finan. | 0 | -72 | -418 | |
| Net Change | 0 | -4 | -37 | |
| Cash & Cash Eqvt | 0 | 73 | 38 |
|
Mon, 23 Jan 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (the Listing Regulations) we wish to inform you that the Company is organizing a Conference Call on January 31 2023 after submission of the financial results for the quarter ended December 31 2022 to the Stock Exchanges. Details of the Conference Call are attached. |
|
Mon, 23 Jan 2023
Corporate Action-Board to consider Dividend In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday January 31 2023 to inter-alia consider unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31 2022 and declaration of Interim Dividend for the financial year 2022-2023 if any. |
|
Mon, 23 Jan 2023
Board Meeting Intimation for Intimation Of Board Meeting - January 31 2023 Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday January 31 2023 to inter-alia consider unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31 2022 and declaration of Interim Dividend for the financial year 2022-2023 if any. |
| Mon, 30 Jan 2023 |
Close Crossing Last Week Low
|
Closing Below Previous Low
|
Making Lower Lows for 3 days
|
Close Below Last Week Low
|
Close Below Last Month Low
|
Equities
M.F.
Sectors